Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
about
Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus speciesInfected abdominal aortic aneurysm due to penicillin-, ceftriaxone-, and cefotaxime-resistant Streptococcus pneumoniaePneumococcal resistance in southwest Virginia.Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan.Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies.Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media.Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agentsPostantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococciAntipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology.Antibiotic susceptibility patterns of Streptococcus pneumoniae in china and comparison of MICs by agar dilution and E-test methods.In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniaeSusceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia modelStudy of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologyLumbar vertebral osteomyelitis with mycotic abdominal aortic aneurysm caused by highly penicillin-resistant Streptococcus pneumoniae.Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologiesAntipneumococcal activities of gemifloxacin compared to those of nine other agentsAntipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci.Antipneumococcal activity of ABT-773 compared to those of 10 other agents.Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniaeDetermination of penicillin MICs for Streptococcus pneumoniae by using a two- or three-disk diffusion procedure.Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia.Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin.Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolatesMIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciActivities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologiesComparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methodsMIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptibleIn vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents.Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococciMIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agentsSusceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, a
P2860
Q24564933-585C0C7B-566E-4C3A-9E06-5D845CADE709Q28378935-04484C0A-FA84-4ABF-9F49-A3DD49166A65Q30452917-BA9D2428-215C-4803-999E-921B7F5DF8B3Q33672446-FBC8AF9A-06EE-496E-9463-90F3579B9854Q33685617-0A24F0C2-3822-43D2-8049-0E8917BBF47BQ33691073-9D5DD88B-D100-48CC-B67D-4DC04E32F65FQ33691239-D9669318-89C9-4763-9B5A-56DF99064C5BQ33696032-06F6C5A9-22E7-492C-9477-CB4D206B26C9Q33696166-B758FEAD-30E4-4E92-A981-876A5385E90AQ33699406-DD71E81B-BB11-475A-9AFB-8D0198B7B951Q33701390-6681968A-B1A6-479D-8AB0-0C6AD1E6B3DBQ33753762-D1CB3F0C-AEB6-4234-A177-199DEDEE6E12Q33757851-E4113574-43AA-43CC-A437-05EDAA21B769Q33758620-AA2E68E0-FA03-4FA0-9B5C-1B04818245B6Q33964464-8A725E76-11BC-4A33-896F-4F3B0289C6FBQ33966371-EBC49E8A-F184-4D29-B7BF-6E08DF456CDDQ33978679-D944C75F-5433-43DC-A015-FE6F97C4A0E7Q33979265-A7ED3C0C-4ABB-470A-A905-A41CC63CB21AQ33980037-6B1E3D8B-8258-43C3-86C8-9835F98C70ABQ34008890-1B7EBE92-22E6-47D5-B340-B67F48A57100Q34073085-263E99BD-B5FD-4244-A067-6EAD5D7075E5Q34112023-78D4B33F-2846-45E0-8F7E-C97F179489CCQ35115070-7EF734A5-AEA2-4BB6-AB90-23C1D95CE910Q35116103-807D4050-ADD2-4FF0-A741-1218D77257B0Q35119197-0C3D134E-A521-4560-AAEB-D9A2BA1A89F0Q35122364-718CA3FC-5306-46DA-BEC4-A804B900CB76Q35122591-EF29A5EF-3BC5-461F-985A-4E25EC561B80Q35123654-6D7F7583-6350-4E36-A068-B8675B8F298CQ35125580-546FF5F7-6325-4D95-A22E-41501F452404Q35126352-E4B9BC45-F98D-4246-AB2E-AC492272606EQ35126435-6A99DB2D-AFF0-429B-BB63-E611FF2F7892Q35126660-B19F0D61-425A-4060-9C1A-104E25FAEF31Q35128604-DA2110ED-18A4-4570-84E8-FDF16DE37C11Q35129463-6DF59CC7-561F-4279-B5C8-6BF13883F379Q35131455-8A03A734-DF35-44F0-86C0-F115EB3D0AC9Q35135982-028110F4-6193-40F2-BB1A-029E6847B6B7Q35137932-8278D6A5-77F0-4257-BC40-4A8FD2A15F64Q35138485-4EC49A8A-F1CD-4209-819D-44735D8685ABQ35139557-77EE556D-0BF3-4E7A-BC1B-0D4D9AE29AC9Q35823398-A2153671-9E0E-432D-920E-3690B5AA7865
P2860
Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
@ast
Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
@en
type
label
Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
@ast
Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
@en
prefLabel
Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
@ast
Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
@en
P356
P1476
Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.
@en
P2093
P304
P356
10.1093/CLINIDS/15.1.119
P407
P577
1992-07-01T00:00:00Z